Trend Following
(11)
▼
Momentum
(6)
▼
Volatility
(5)
▼
Pattern Recognition
(5)
▼
Mean Reversion
(4)
▼
Volume Based
(5)
▼
Advanced
(10)
▼
LQDA
$33.57
$
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Next Earnings
2026-02-25
Beta
0.472
Average Volume
Market Cap
Last Dividend
CIK
0001819576
ISIN
US53635D2027
CUSIP
53635D202
CEO
Roger A. Jeffs
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
170
IPO Date
2018-07-26
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| Liquidia (NASDAQ:LQDA) Trading Down 5% – Here’s Why | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) shares traded down 5% during mid-day trading on Friday. The stock traded as low as $33.57 and last traded at $33.2860. 116,169 shares traded hands during trading, a decline of 94% from the average session volume of 2,104,083 shares. The stock had previously closed at $35.05. Analysts | Defense World | 2026-02-22 04:36:57 |
| EXEL or LQDA: Which Is the Better Value Stock Right Now? | Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis (EXEL) or Liquidia Corporation (LQDA). But which of these two stocks offers value investors a better bang for their buck right now? | Zacks Investment Research | 2026-02-12 12:41:08 |
| SG Americas Securities LLC Decreases Stock Position in Liquidia Corporation $LQDA | SG Americas Securities LLC lessened its stake in Liquidia Corporation (NASDAQ: LQDA) by 33.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 37,289 shares of the company's stock after selling 19,074 shares during the period. SG Americas Securities | Defense World | 2026-01-20 06:33:15 |
| Liquidia (NASDAQ:LQDA) Sets New 12-Month High – Should You Buy? | Liquidia Corporation (NASDAQ: LQDA - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Friday. The stock traded as high as $41.57 and last traded at $38.79, with a volume of 2374182 shares trading hands. The stock had previously closed at $39.99. Trending Headlines about Liquidia Here are the key | Defense World | 2026-01-18 02:04:31 |
| Liquidia Corporation (LQDA) is a Great Momentum Stock: Should You Buy? | Does Liquidia Corporation (LQDA) have what it takes to be a top stock pick for momentum investors? Let's find out. | Zacks Investment Research | 2026-01-15 13:01:17 |
| Scott Moomaw Sells 20,533 Shares of Liquidia (NASDAQ:LQDA) Stock | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) insider Scott Moomaw sold 20,533 shares of the business's stock in a transaction on Monday, January 12th. The stock was sold at an average price of $37.43, for a total value of $768,550.19. Following the sale, the insider owned 154,514 shares of the company's stock, valued at approximately | Defense World | 2026-01-15 05:36:47 |
| Rajeev Saggar Sells 21,142 Shares of Liquidia (NASDAQ:LQDA) Stock | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) insider Rajeev Saggar sold 21,142 shares of the firm's stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $37.43, for a total transaction of $791,345.06. Following the completion of the transaction, the insider owned 176,883 shares in the | Defense World | 2026-01-15 05:36:47 |
| Jason Adair Sells 13,548 Shares of Liquidia (NASDAQ:LQDA) Stock | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) insider Jason Adair sold 13,548 shares of the business's stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $37.43, for a total value of $507,101.64. Following the completion of the transaction, the insider directly owned 184,174 shares in | Defense World | 2026-01-15 05:36:47 |
| Russell Schundler Sells 27,289 Shares of Liquidia (NASDAQ:LQDA) Stock | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) General Counsel Russell Schundler sold 27,289 shares of the firm's stock in a transaction on Monday, January 12th. The shares were sold at an average price of $37.43, for a total transaction of $1,021,427.27. Following the sale, the general counsel owned 579,394 shares in the company, valued at | Defense World | 2026-01-15 05:36:46 |
| Sarah Krepp Sells 13,165 Shares of Liquidia (NASDAQ:LQDA) Stock | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) insider Sarah Krepp sold 13,165 shares of the firm's stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $37.43, for a total transaction of $492,765.95. Following the completion of the sale, the insider directly owned 140,769 shares in | Defense World | 2026-01-15 05:36:45 |
| Dana Boyle Sells 11,047 Shares of Liquidia (NASDAQ:LQDA) Stock | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) CAO Dana Boyle sold 11,047 shares of the company's stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $37.43, for a total transaction of $413,489.21. Following the transaction, the chief accounting officer owned 156,700 shares in the company, valued at | Defense World | 2026-01-15 04:45:04 |
| Michael Kaseta Sells 36,932 Shares of Liquidia (NASDAQ:LQDA) Stock | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) CFO Michael Kaseta sold 36,932 shares of the business's stock in a transaction on Monday, January 12th. The shares were sold at an average price of $37.43, for a total transaction of $1,382,364.76. Following the completion of the sale, the chief financial officer owned 350,919 shares in the | Defense World | 2026-01-15 04:04:56 |
| Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript | Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript | Seeking Alpha | 2026-01-14 22:25:59 |
| Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 66,610 Shares | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) CEO Roger Jeffs sold 66,610 shares of the company's stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $37.43, for a total value of $2,493,212.30. Following the transaction, the chief executive officer directly owned 1,037,528 shares in the | Defense World | 2026-01-14 04:48:54 |
| Liquidia (NASDAQ:LQDA) Shares Up 9.1% – Should You Buy? | Liquidia Corporation (NASDAQ: LQDA - Get Free Report) traded up 9.1% during trading on Friday. The stock traded as high as $34.57 and last traded at $34.6550. 1,890,581 shares were traded during mid-day trading, an increase of 14% from the average session volume of 1,665,680 shares. The stock had previously closed at $31.76. Trending Headlines | Defense World | 2026-01-11 04:56:46 |
| Why Liquidia Stock Rocked the Market Today | The biotech posted preliminary sales results for Yutrepia. This is its latest commercialized product, approved by the FDA in May 2025. | The Motley Fool | 2026-01-09 18:49:20 |
| Liquidia: Yutrepia's Attributes In Focus, But Binary Risk Shouldn't Be Ignored | Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and product differentiation in PAH and PH-ILD. LQDA's Yutrepia demonstrates superior tolerability, higher achievable dosing, and rapid titration versus Tyvaso, driving robust commercial uptake and market share gains. Key binary risk centers on the imminent IP litigation outcome versus United Therapeutics; multiple scenarios could impact valuation, but commercial momentum is strong. | Seeking Alpha | 2026-01-08 14:00:20 |
| HRMY vs. LQDA: Which Stock Is the Better Value Option? | Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Harmony Biosciences Holdings, Inc. (HRMY) and Liquidia Corporation (LQDA). But which of these two stocks presents investors with the better value opportunity right now? | Zacks Investment Research | 2026-01-08 12:40:37 |
| Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus | Liquidia shares have surged 43.9% since an October upgrade, as Zacks highlights stock wins and portfolio results despite a volatile market. | Zacks Investment Research | 2025-12-15 10:11:03 |
| AWH Capital L.P. Takes $866,000 Position in Liquidia Corporation $LQDA | AWH Capital L.P. bought a new position in shares of Liquidia Corporation (NASDAQ: LQDA) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 69,500 shares of the company's stock, valued at approximately $866,000. Liquidia comprises 1.0% of | Defense World | 2025-12-13 03:54:52 |
SEC Filings
| Type | Filing Date | Accepted Date | Link |
|---|---|---|---|
| 4 | 2026-02-12 | 2026-02-12 | View Filing |
| SC 13G/A | 2026-02-09 | 2026-02-09 | View Filing |
| 4 | 2026-01-28 | 2026-01-28 | View Filing |
| 4 | 2026-01-28 | 2026-01-28 | View Filing |
| 4 | 2026-01-21 | 2026-01-21 | View Filing |
| 4 | 2026-01-21 | 2026-01-21 | View Filing |
| 4 | 2026-01-21 | 2026-01-21 | View Filing |
| 4 | 2026-01-21 | 2026-01-21 | View Filing |
| 4 | 2026-01-21 | 2026-01-21 | View Filing |
| 4 | 2026-01-21 | 2026-01-21 | View Filing |
| 4 | 2026-01-21 | 2026-01-21 | View Filing |
| 4 | 2026-01-21 | 2026-01-21 | View Filing |
| 4 | 2026-01-21 | 2026-01-21 | View Filing |
| 4 | 2026-01-13 | 2026-01-13 | View Filing |
| 4 | 2026-01-13 | 2026-01-13 | View Filing |
| 4 | 2026-01-13 | 2026-01-13 | View Filing |
| 4 | 2026-01-13 | 2026-01-13 | View Filing |
| 4 | 2026-01-13 | 2026-01-13 | View Filing |
| 4 | 2026-01-13 | 2026-01-13 | View Filing |
| 4 | 2026-01-13 | 2026-01-13 | View Filing |
| 4 | 2026-01-13 | 2026-01-13 | View Filing |
| 3 | 2026-01-13 | 2026-01-13 | View Filing |
| 8-K | 2026-01-09 | 2026-01-09 | View Filing |
| 4 | 2025-12-02 | 2025-12-02 | View Filing |
| 4 | 2025-12-02 | 2025-12-02 | View Filing |
| 4 | 2025-12-02 | 2025-12-02 | View Filing |
| 4 | 2025-12-02 | 2025-12-02 | View Filing |
| 4 | 2025-12-02 | 2025-12-02 | View Filing |
| 4 | 2025-12-02 | 2025-12-02 | View Filing |
| 4 | 2025-11-20 | 2025-11-20 | View Filing |
| 4 | 2025-11-12 | 2025-11-12 | View Filing |
| SC 13G/A | 2025-11-12 | 2025-11-12 | View Filing |
| 4 | 2025-11-07 | 2025-11-07 | View Filing |
| 10-Q | 2025-11-03 | 2025-11-03 | View Filing |
| 8-K | 2025-11-03 | 2025-11-03 | View Filing |
| 8-K | 2025-10-30 | 2025-10-30 | View Filing |
| 4 | 2025-10-29 | 2025-10-29 | View Filing |
| 4 | 2025-10-29 | 2025-10-29 | View Filing |
| 4 | 2025-10-15 | 2025-10-15 | View Filing |
| 4 | 2025-10-15 | 2025-10-15 | View Filing |
| 4 | 2025-10-15 | 2025-10-15 | View Filing |
| 4 | 2025-10-15 | 2025-10-15 | View Filing |
| 4 | 2025-10-15 | 2025-10-15 | View Filing |
| 4 | 2025-10-15 | 2025-10-15 | View Filing |
| 4 | 2025-10-15 | 2025-10-15 | View Filing |
| 4 | 2025-10-15 | 2025-10-15 | View Filing |
| 4/A | 2025-09-17 | 2025-09-17 | View Filing |
| 4 | 2025-09-17 | 2025-09-17 | View Filing |
| 4 | 2025-09-05 | 2025-09-05 | View Filing |
| 4 | 2025-09-03 | 2025-09-03 | View Filing |
| 4 | 2025-09-03 | 2025-09-03 | View Filing |
| 4 | 2025-09-03 | 2025-09-03 | View Filing |
| 4 | 2025-09-03 | 2025-09-03 | View Filing |
| 4 | 2025-09-03 | 2025-09-03 | View Filing |
| 4 | 2025-09-02 | 2025-09-02 | View Filing |
| 4 | 2025-09-02 | 2025-09-02 | View Filing |
| 4 | 2025-09-02 | 2025-09-02 | View Filing |
| 4 | 2025-08-21 | 2025-08-21 | View Filing |
| 4 | 2025-08-19 | 2025-08-19 | View Filing |
| 10-Q | 2025-08-12 | 2025-08-12 | View Filing |
| 8-K | 2025-08-12 | 2025-08-12 | View Filing |
| 4 | 2025-08-07 | 2025-08-07 | View Filing |
| 4 | 2025-07-30 | 2025-07-30 | View Filing |
| 4 | 2025-07-30 | 2025-07-30 | View Filing |
| 4 | 2025-07-23 | 2025-07-23 | View Filing |
| 4 | 2025-07-15 | 2025-07-15 | View Filing |
| 4 | 2025-07-15 | 2025-07-15 | View Filing |
| 4 | 2025-07-15 | 2025-07-15 | View Filing |
| 4 | 2025-07-15 | 2025-07-15 | View Filing |
| 4 | 2025-07-15 | 2025-07-15 | View Filing |
| 4 | 2025-07-15 | 2025-07-15 | View Filing |
| 4 | 2025-07-15 | 2025-07-15 | View Filing |
| 4 | 2025-07-15 | 2025-07-15 | View Filing |
| 4 | 2025-07-15 | 2025-07-15 | View Filing |
| SC 13G | 2025-07-11 | 2025-07-11 | View Filing |
| 4 | 2025-07-03 | 2025-07-03 | View Filing |
| 4 | 2025-07-03 | 2025-07-03 | View Filing |
| 3 | 2025-07-03 | 2025-07-03 | View Filing |
| 3 | 2025-07-03 | 2025-07-03 | View Filing |
| 8-K | 2025-07-01 | 2025-07-01 | View Filing |
| 8-K | 2025-06-24 | 2025-06-23 | View Filing |
| 4 | 2025-06-20 | 2025-06-20 | View Filing |
| 4 | 2025-06-20 | 2025-06-20 | View Filing |
| 4 | 2025-06-20 | 2025-06-20 | View Filing |
| 4 | 2025-06-20 | 2025-06-20 | View Filing |
| 4 | 2025-06-20 | 2025-06-20 | View Filing |
| 4 | 2025-06-20 | 2025-06-20 | View Filing |
| 4 | 2025-06-20 | 2025-06-20 | View Filing |
| 4 | 2025-06-20 | 2025-06-20 | View Filing |
| 8-K | 2025-06-18 | 2025-06-18 | View Filing |
| 8-K | 2025-06-18 | 2025-06-18 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-05 | 2025-06-05 | View Filing |
| 4 | 2025-06-03 | 2025-06-03 | View Filing |
| 4 | 2025-06-03 | 2025-06-03 | View Filing |
| 4 | 2025-06-03 | 2025-06-03 | View Filing |
Algorithm Performance
Upgrade To Premium for Full Access
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|---|---|---|---|---|---|
| Larry Williams PercentR Strategy | 28.86% | 1.4 | 21 | 0.76 | 1.22 | 37.56 |
| Swarm Intelligence Strategy | 25.89% | 0.97 | 39 | 0.58 | 0.32 | 34.58 |
| Williams PercentR Strategy | 22.79% | 1.8 | 27 | 0.75 | 0 | 26.49 |
| xxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxx% | xxxx | x | xxxx | xxxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | x | xxxx | xxxx | xxxxx |
| xxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxx |
| xxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | x | xxxx | xxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxx | xxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxx | xxxx% | x | x | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxx |
| xxxxxxxxx | xxxxxxx% | xxxx | x | xxx | xxxx | xxxx |
| xxx | xxxxxxx% | xxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | x |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxx | xxxx | xxxx |
| xxxxxxxxx | xxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxx | xxxxxx% | xxxx | x | xxx | xxxx | xxxx |
| xxxxxxxxx | xxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxx | xxxxxx% | xxxx | x | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxx | xxxxx% | x | x | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxx% | x | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxx% | xxxx | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxx | x% | x | x | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxx | x% | x | x | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | x | x | x | x | xxx |
| xxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxx | x% | x | x | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | x | xx | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | x | x | x | x | xxx |
| xxxxxxxxxxxxxxxxxxxxx | x% | x | x | x | x | xxx |
| xxxx | x% | x | xx | x | x | xxx |
| xxxx | xxxxxxx% | x | xx | xxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xx | xxxxx | xxx |
| xxxxxxxxx | xxxxxxx% | xxxx | xx | xxxxx | xxxxx | x |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xx | xxxx | xxxx | xxxx |
| xxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxx | xxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xx | xxxxx | xxxxx | xxxx |
| xxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxx |
| xxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxx | xxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxx | xxxxxxxx% | x | xx | xxxxx | xxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxx | xxxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxx | xxxxx | x |
| xxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxx |
| xxx | xxxxxxxx% | xxxx | x | xxxx | xxxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | x |
| xxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxx |
| xxxxxxxxx | xxxxx% | xxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxx |
| xxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | x |
| xxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxxx |